Abnormalities of retinal metabolism in diabetes and experimental galactosemia VII. Effect of long-term administration of antioxidants on the development of retinopathy
Ra. Kowluru et al., Abnormalities of retinal metabolism in diabetes and experimental galactosemia VII. Effect of long-term administration of antioxidants on the development of retinopathy, DIABETES, 50(8), 2001, pp. 1938-1942
Antioxidants were administered to diabetic rats and experimentally galactos
emic rats to evaluate the ability of these agents to inhibit the developmen
t of diabetic retinopathy. Alloxan diabetic rats and nondiabetic rats that
were fed 30% galactose randomly received standard diets or the diets supple
mented with ascorbic acid and alpha -tocopherol (vitamins C+E diet) or a mo
re comprehensive mixture of antioxidants (multi-antioxidant diet), includin
g Trolox, alpha -tocopherol, N-acetyl cysteine, ascorbic acid, beta -carote
ne, and selenium. Diabetes or galactose feeding of at least 12 months resul
ted in pericyte loss, acellular capillaries, and basement membrane thickeni
ng. Compared with diabetic controls, the development of acellular capillari
es was inhibited by 50% (P < 0.05) in diabetic rats that received supplemen
tal vitamins C+E, and the number of pericyte ghosts tended to be reduced. T
he vitamins C+E supplement had no beneficial effect in galactosemic rats, b
ut these rats consumed only approximately half as much of the antioxidants
as the diabetic rats. The multi-antioxidant diet significantly inhibited (s
imilar to 55-65%) formation of both pericyte ghosts and acellular capillari
es in diabetic rats and galactosemic rats (P < 0.05 vs. controls), without
affecting the severity of hyperglycemia. Parameters of retinal oxidative st
ress, protein kinase C activity, and nitric oxides remained elevated for at
least I year of hyperglycemia, and these abnormalities were normalized by
multi-antioxidant therapy. Thus, longterm administration of antioxidants ca
n inhibit the development of the early stages of diabetic retinopathy, and
the mechanism by which this action occurs warrants further investigation, S
upplementation with antioxidants can offer an achievable and inexpensive ad
junct therapy to help inhibit the development of retinopathy in diabetes.